Myasthenia Gravis Generalized
📧 Sign up to get email alerts when something new happens for Myasthenia Gravis Generalized.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Study of Telitacicept in Generalized Myasthenia Gravis [Phase 3]
A Phase 3 study evaluating Telitacicept in generalized myasthenia gravis has completed, according to the clinical trial update.
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG) [Phase 3]
This Phase 3 open-label crossover trial evaluating self-administration of Rozanolixizumab in generalized myasthenia gravis has completed, wi…
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis [Phase 2, Phase 3]
Open-label extension study of tocilizumab in generalized myasthenia gravis (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis [Phase 3]
Phase 3 trial results evaluate safety, tolerability, and efficacy of zilucoplan in generalized myasthenia gravis; the study is completed and…
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG [Phase 3]
Phase 3 trial evaluating amifampridine phosphate in generalized myasthenia gravis (MuSK-MG) has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-25Clinical Trial Update: Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis [Phase 2]
Phase 2 trial assessing safety, tolerability, PK, and efficacy of CFZ533 in moderate to severe generalized myasthenia gravis has completed w…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis [Phase 2]
Phase 2 trial evaluating intravenous immunoglobulin (IGIV-C) for efficacy and safety in symptomatic generalized myasthenia gravis has comple…